Peter Chase, MD
Clinical Professor, Pediatrics-Barbara Davis Center

Clinic (303) 724-2323
Print Profile
Email Profile

Gender: Male
Languages: English
Department, Section/Division: Pediatrics-Barbara Davis Center

Practice Locations

Barbara Davis Center for Childhood Diabetes - Specialty Clinic
1775 Aurora Ct
Aurora, CO 80045

Hospital Affiliation
  • Children's Hospital Colorado
Center Affiliations

Specialty Information

  • Pediatrics - Pediatric Endocrinology, Board Certification
Conditions & Treatments
  • Child and Teen Health - Juvenile Diabetes

Information for Referring Providers

Clinical Interests for Referring Providers
Pediatric Diabetes

Research Interest for Referring Providers
Clinical trials of agents for the prevention of type I diabetes, including cyclosporine, nicotinamide, BCG and the subcutaneous and intravenous administration of insulin. He is currently one of nine center directors for the Diabetes Prevention Trial (DPT-1). Development of strategies aimed at prevention of the eye and kidney complications of type I diabetes, based upon controlling HbA1c levels and blood pressure levels. His first longitudinal report of HbA1c levels in relation to diabetic eye and kidney complications was reported in JAMA in 1989. The development of new insulins and their use in children: he was the first to report the use of postprandial Humalog in toddlers and on the use of Humalog in the phone management of ketonuria. Ketoacidosis has been of interest for many years (Pediatrics in Review, 1990). A report is now in progress relating to the prevention of severe DKA and cerebral edema. Continuous glucose monitoring (CGM) in children has been a recent area of emphasis. The use of CGM to prevent severe hypoglycemia and to improve HbA1c levels is currently being studied

Clinic Phone: (303) 724-2323
Fax Phone: (303) 724-6784
Contact Us
In An Emergency: Please Dial 911

University Physicians, Inc. (UPI)
Refer a Patient: 720-848-2828
Billing Questions: 303-493-7000

Twitter   Facebook
CU Doctors